Summary of Financial Statements
for First Quarter of Fiscal Year Ending March 31, 2021 [Japanese GAAP]
(Consolidated)
August 7, 2020 | ||||
Name of listed company: | SHIP HEALTHCARE HOLDINGS, INC. | |||
Shares listed on: Tokyo Stock Exchange | ||||
Code: | 3360 | URL | https://www.shiphd.co.jp/ | |
Representative: | Kunihisa Furukawa, Chairman and CEO | |||
Contact: | Hiroshi Yokoyama, Executive Director | Tel.: +81-6-6369-0130 | ||
Scheduled date for filing quarterly report: | August 12, 2020 | Scheduled start date of dividend payments: - | ||
Supplementary briefing materials on results: | None | |||
Briefing on quarterly results: | None |
(All figures are rounded down to the nearest million yen.)
1. Consolidated financial results for the first quarter of fiscal year ending March 31, 2021 (April 1 - June 30, 2020)
(1) Consolidated operating results (cumulative) | (Percentages represent year-on-year changes.) | ||||||||||||||||||
Net sales | Operating profit | Ordinary profit | Profit attributable to | ||||||||||||||||
owners of parent | |||||||||||||||||||
(Millions yen) | % | (Millions yen) | % | (Millions yen) | % | (Millions yen) | % | ||||||||||||
Q1 FY ending March 2021 | 105,455 | (3.3) | 2,887 | (4.7) | 3,064 | (5.5) | 1,643 | (11.4) | |||||||||||
Q1 FY ended March 2020 | 109,005 | 10.6 | 3,030 | 10.2 | 3,242 | 8.7 | 1,855 | 4.7 | |||||||||||
Note: Comprehensive income: Q1 FY ending March 2021: ¥3,343 million (94.4%) | |||||||||||||||||||
Q1 FY ended March 2020: ¥1,719 million ((17.3)%) | |||||||||||||||||||
Basic earnings per | Diluted earnings per | ||||||||||||||||||
share | share | ||||||||||||||||||
(Yen) | (Yen) | ||||||||||||||||||
Q1 FY ending March 2021 | 34.70 | 31.45 | |||||||||||||||||
Q1 FY ended March 2020 | 38.96 | 35.36 | |||||||||||||||||
(2) Consolidated financial condition | |||||||||||||||||||
Total assets | Net assets | Equity capital ratio | |||||||||||||||||
(Millions yen) | (Millions yen) | % | |||||||||||||||||
Q1 FY ending March 2021 | 298,628 | 104,280 | 33.7 | ||||||||||||||||
FY ended March 2020 | 308,873 | 104,681 | 33.0 | ||||||||||||||||
Reference: Equity: Q1 FY ending March 2021: ¥100,753 million; FY ended March 2020: ¥101,784 million | |||||||||||||||||||
2. Dividends | |||||||||||||||||||
Annual dividends | |||||||||||||||||||
End Q1 | End Q2 | End Q3 | Year-end | Total | |||||||||||||||
(Yen) | (Yen) | (Yen) | (Yen) | (Yen) | |||||||||||||||
FY ended March 2020 | - | 0.00 | - | 75.00 | 75.00 | ||||||||||||||
FY ending March 2021 | - | ||||||||||||||||||
FY ending March 2021 | 0.00 | - | 77.00 | 77.00 | |||||||||||||||
(forecast) | |||||||||||||||||||
Notes: Revisions made in most recently announced dividend forecasts: None |
3. Forecast of consolidated financial results for fiscal year ending March 31, 2021 (April 1, 2020 - March 31, 2021)
(Percentages represent changes from previous year for full-year figures and year-on-year changes for quarterly figures.)
Net sales | Operating profit | Ordinary profit | Profit attributable to | Basic earnings | ||||||
owners of parent | per share | |||||||||
Cumulative through | (Millions yen) | % | (Millions yen) | % | (Millions yen) | % | (Millions yen) | % | (Yen) | |
240,000 | (0.9) | 6,900 | (31.6) | 6,900 | (37.3) | 4,000 | (40.2) | 84.55 | ||
second quarter | ||||||||||
Full-year | 500,000 | 3.2 | 21,000 | 11.7 | 21,000 | 5.4 | 12,100 | 2.5 | 255.96 | |
Note: Revisions made in most recently announced forecasts of business performance: None |
Notes
(1) | Changes made in significant subsidiaries during consolidated cumulative quarter under review: | None | |
(2) | Special account processing applied in preparation of quarterly consolidated financial statements: | None | |
(3) | Changes made in accounting policies, accounting estimates, and/or restatements | ||
(i) | Changes in accounting policies associated with changes in accounting standards, etc.: | None | |
(ii) | Any changes in accounting policies other than those under (i) above: | None | |
(iii) Changes in accounting estimates: | None | ||
(iv) Restatements: | None | ||
(4) | Number of shares issued and outstanding (common shares) |
- Number of shares issued and outstanding at the end of the period (including treasury shares)
- Number of treasury shares at the end of the period
- Average number of shares during the period (quarterly cumulative total)
Q1 FY ending | 50,834,700 shares | FY ended March | 50,834,700 shares |
March 2021 | 2020 | ||
Q1 FY ending | 3,600,927 shares | FY ended March | 3,420,627 shares |
March 2021 | 2020 | ||
Q1 FY ending | 47,361,298 shares | Q1 FY ended | 47,630,157 shares |
March 2021 | March 2020 | ||
- This quarterly summary of financial results is not subject to quarterly review by a Certified Public Accountant or an audit firm.
- Information on appropriate use of financial forecasts and other special notes:
- The forecasts of financial results and other forward-looking statements provided herein are based on information available to the Company and assumptions considered reasonable at the time this document was prepared. They are not guarantees that the Company will achieve such forecasts. Actual results may differ significantly from the forecasts for various reasons. For the assumptions on which financial forecasts are based, notes on using financial forecasts, and other information, please refer to "Information on consolidated financial forecasts and other forward-looking statements" on page 3 of the attached materials.
SHIP HEALTHCARE HOLDINGS, INC. (3360): Summary of Financial Statements for First Quarter of Fiscal Year Ending March 31, 2021
- Index of attached materials
Information on consolidated financial forecasts and other forward-looking statements .......................... | |||
1
SHIP HEALTHCARE HOLDINGS, INC. (3360): Summary of Financial Statements for First Quarter of Fiscal Year Ending March 31, 2021
1. Qualitative information on quarterly results
(1) Description of business results
During the first quarter of the current consolidated cumulative period, business confidence in Japanese economy deteriorated rapidly due to the expansion of COVID-19, which significantly limited economic and social activities, and reduced personal consumption and corporate profits. As for the global economy, the outlook remains uncertain due to the rapid expansion of COVID-19 and the intensifying conflict between the United States and China.
Within the healthcare industry in which the Group operates, it is at the forefront of the field against COVID-19, and while medical staff are doing their utmost work day and night regardless of the risk of the infectious disease, the Group has also endeavored to secure necessary items such as medical equipment and medical materials, and provided maximum support. On the other hand, with regard to conventional medical care, there are some situations in which hospital earnings must be difficult, as treatment that is not urgent has been delayed.
Under these economic conditions, the Group's Medical Supply business performed steadily, and high occupancy rate has been maintained in Life Care business as in the previous term. On the other hand, the projects in Total Pack Produce business tended to be weighted in the second half compared to the previous fiscal year, and Dispensing Pharmacy business remained difficult due to the effects of revisions of dispensing fees and drug prices.
During this consolidated cumulative first quarter, the various factors noted above resulted in net sales of 105,455 million yen (down 3.3% YoY), operating profit of 2,887 million yen (down 4.7% YoY), ordinary profit of 3,064 million yen (down 5.5% YoY), and profit attributable to owners of the parent of 1,643 million yen (down 11.4% YoY).
Business results by segment are summarized below.
-
Total Pack Produce business
Total Pack Produce business was in difficult situation due to the tendency that the projects weighted in the second half compared to the previous fiscal year although the performance of the newly consolidated medical device distribution company in Myanmar contributed.
As a result, this segment recorded net sales of 16,806 million yen (down 13.1% YoY) and segment profit (operating profit) of 976 million yen (down 14.4% YoY). - Medical Supply business
Driven by group cooperation and improvements in operational efficiency, Medical Supply business was generally in line with the plan although the profitability has continued to be difficult due to the impact of the redemption price revision.
As a result, this segment recorded net sales of 74,275 million yen (down 2.1% YoY) and segment profit (operating profit) of 850 million yen (up 8.0% YoY). - Life Care business
As management efficiency has advanced due to the well-established nationwide integrated management and increase in occupancy rate, Life Care business performed steadily.
As a result, this segment recorded net sales of 6,069 million yen (up 1.6% YoY) and segment profit (operating profit) of 580 million yen (up 31.4% YoY). - Dispensing Pharmacy business
In the Dispensing Pharmacy business, the condition remained difficult due to the restraint in visiting medical institutions as the expansion of COVID-19 in addition to the effects of revisions to dispensing fees and drug prices.
As a result, this segment recorded net sales of 6,551 million yen (down 1.0% YoY) and segment profit (operating profit) of 446 million yen (down 28.5% YoY). - Other businesses
Other businesses resulted in inactive as the security support company performed poorly due to the decline in operation ratio of the facilities of clients while the performance of building management company newly contributed.
As a result, this segment recorded net sales of 1,753 million yen (up 47.0% YoY) and segment profit (operating profit) of 86 million yen (down 13.2% YoY).
2
SHIP HEALTHCARE HOLDINGS, INC. (3360): Summary of Financial Statements for First Quarter of Fiscal Year Ending March 31, 2021
(2) Analysis of financial position
Assets at the end of the consolidated first quarter under review stood at 298,628 million yen, down 10,244 million yen from the end of the previous consolidated fiscal year. The primary reasons for this decline included decreases of 14,705 million yen in cash and deposits, and 11,327 million yen in notes and accounts receivable - trade, despite increases of 11,348 million yen in investment securities, and 2,872 million yen in merchandise and finished goods.
Liabilities stood at 194,347 million yen, down 9,844 million yen from the end of the previous consolidated fiscal year. The primary reasons for this decline included decreases of 11,731 million yen in notes and accounts payable - trade, and 3,284 million yen in income taxes payable, despite increases of 3,775 million yen in short-term loans.
Net assets were 104,280 million yen, down 400 million yen from the end of the previous consolidated fiscal year. The primary reasons for this decline included a decrease of 3,556 million yen in retained earnings due to payment of dividends, despite increase of 1,707 million yen in valuation difference on available-for-sale securities, and 1,643 million yen in retained earnings from profit attributable to owners of parent.
As a result of all these factors, the equity capital ratio at the end of the consolidated first quarter under review stood at 33.7%. (up 0.7% from the end of the previous consolidated fiscal year)
(3) Information on consolidated financial forecasts and other forward-looking statements
In general, business performance matched financial forecasts made at the start of the period. The consolidated financial forecasts for the cumulative second quarter and the full fiscal year remain unchanged from the forecasts announced on May 12, 2020.
3
SHIP HEALTHCARE HOLDINGS, INC. (3360): Summary of Financial Statements for First Quarter of Fiscal Year Ending March 31, 2021
2. Quarterly consolidated financial statements and notes thereto
- Quarterly consolidated balance sheet
(Unit: Millions yen) | ||||||||
March 31, 2020 | June 30, 2020 | |||||||
Assets | ||||||||
Current assets | ||||||||
Cash and deposits | 78,717 | 64,012 | ||||||
Notes and accounts receivable - trade | 95,623 | 84,295 | ||||||
Electronically recorded monetary claims - operating | 3,611 | 3,885 | ||||||
Lease investment assets | 3,500 | 3,454 | ||||||
Merchandise and finished goods | 14,029 | 16,902 | ||||||
Work in process | 1,511 | 2,009 | ||||||
Raw materials and supplies | 845 | 1,035 | ||||||
Other | 12,731 | 10,421 | ||||||
Allowance for doubtful accounts | (71) | (141) | ||||||
Total current assets | 210,499 | 185,876 | ||||||
Non-current assets | ||||||||
Property, plant, and equipment | ||||||||
Buildings and structures, net | 18,534 | 18,423 | ||||||
Land | 16,100 | 16,095 | ||||||
Real estate for rent, net | 11,213 | 11,155 | ||||||
Other, net | 11,166 | 11,130 | ||||||
Total property, plant, and equipment | 57,014 | 56,804 | ||||||
Intangible assets | ||||||||
Goodwill | 8,548 | 11,055 | ||||||
Other | 972 | 941 | ||||||
Total intangible assets | 9,520 | 11,997 | ||||||
Investments and other assets | ||||||||
Investment securities | 14,535 | 25,883 | ||||||
Long-term loans receivable | 7,810 | 7,742 | ||||||
Other | 11,209 | 12,043 | ||||||
Allowance for doubtful accounts | (1,716) | (1,719) | ||||||
Total investments and other assets | 31,838 | 43,950 | ||||||
Total non-current assets | 98,373 | 112,752 | ||||||
Total assets | 308,873 | 298,628 | ||||||
4
SHIP HEALTHCARE HOLDINGS, INC. (3360): Summary of Financial Statements for First Quarter of Fiscal Year Ending March 31, 2021
(Unit: Millions yen) | ||||||||
March 31, 2020 | June 30, 2020 | |||||||
Liabilities | ||||||||
Current liabilities | ||||||||
Notes and accounts payable - trade | 90,121 | 78,389 | ||||||
Electronically recorded obligations - operating | 19,598 | 19,379 | ||||||
Short-term loans | 935 | 4,710 | ||||||
Income taxes payable | 4,400 | 1,115 | ||||||
Provision for bonuses | 2,194 | 2,394 | ||||||
Other | 15,864 | 17,913 | ||||||
Total current liabilities | 133,115 | 123,903 | ||||||
Non-current liabilities | ||||||||
Bonds with share acquisition rights | 25,091 | 25,085 | ||||||
Long-term loans | 36,987 | 35,878 | ||||||
Net defined benefit liability | 2,873 | 2,871 | ||||||
Asset retirement obligations | 838 | 842 | ||||||
Other | 5,284 | 5,767 | ||||||
Total non-current liabilities | 71,076 | 70,444 | ||||||
Total liabilities | 204,191 | 194,347 | ||||||
Net assets | ||||||||
Shareholders' equity | ||||||||
Capital stock | 15,553 | 15,553 | ||||||
Capital surplus | 23,895 | 23,887 | ||||||
Retained earnings | 74,841 | 72,928 | ||||||
Treasury stock | (14,447) | (15,262) | ||||||
Total shareholders' equity | 99,841 | 97,107 | ||||||
Accumulated other comprehensive income | ||||||||
Valuation difference on available-for-sale securities | 2,019 | 3,726 | ||||||
Foreign currency translation adjustment | (152) | (154) | ||||||
Remeasurements of defined benefit plans | 75 | 73 | ||||||
Total accumulated other comprehensive income | 1,942 | 3,645 | ||||||
Non-controlling interests | 2,897 | 3,527 | ||||||
Total net assets | 104,681 | 104,280 | ||||||
Total liabilities and net assets | 308,873 | 298,628 | ||||||
5
SHIP HEALTHCARE HOLDINGS, INC. (3360): Summary of Financial Statements for First Quarter of Fiscal Year Ending March 31, 2021
- Quarterly consolidated statement of income and quarterly consolidated statement of comprehensive income
Quarterly consolidated statement of income
Consolidated cumulative first quarter
(Unit: Millions yen) | |||||||
Three months ended | Three months ended | ||||||
June 30, 2019 | June 30, 2020 | ||||||
Net sales | 109,005 | 105,455 | |||||
Cost of sales | 98,739 | 94,823 | |||||
Gross profit | 10,265 | 10,631 | |||||
Sales, general, and administrative expenses | 7,234 | 7,744 | |||||
Operating profit | 3,030 | 2,887 | |||||
Non-operating income | |||||||
Interest income | 84 | 84 | |||||
Dividend income | 188 | 185 | |||||
Amortization of negative goodwill | 58 | - | |||||
Share of profit of entities accounted for using equity-method | 31 | 34 | |||||
Foreign exchange gains | 3 | 70 | |||||
Reversal of allowance for doubtful accounts | - | 37 | |||||
Other | 95 | 101 | |||||
Total non-operating profit | 461 | 514 | |||||
Non-operating expenses | |||||||
Interest expenses | 63 | 90 | |||||
Provision of allowance for doubtful accounts | 170 | 6 | |||||
Commission fee | 2 | 194 | |||||
Other | 13 | 45 | |||||
Total non-operating expenses | 248 | 337 | |||||
Ordinary profit | 3,242 | 3,064 | |||||
Extraordinary profit | |||||||
Gains on sales of non-current assets | 0 | 0 | |||||
Total extraordinary profit | 0 | 0 | |||||
Extraordinary losses | |||||||
Losses on step acquisitions | - | 92 | |||||
Losses on sales of non-current assets | 2 | - | |||||
Losses on retirement of non-current assets | 0 | 18 | |||||
Total extraordinary losses | 2 | 111 | |||||
Total profit before income taxes | 3,241 | 2,952 | |||||
Income taxes - current | 1,288 | 1,033 | |||||
Income taxes - deferred | 70 | 270 | |||||
Total income taxes | 1,358 | 1,303 | |||||
Profit | 1,883 | 1,649 | |||||
Profit attributable to non-controlling interests | 27 | 5 | |||||
Profit attributable to owners of parent | 1,855 | 1,643 | |||||
6
SHIP HEALTHCARE HOLDINGS, INC. (3360): Summary of Financial Statements for First Quarter of Fiscal Year Ending March 31, 2021
Quarterly consolidated statement of comprehensive income
Consolidated cumulative first quarter
(Unit: Millions yen) | |||||||
Three months ended | Three months ended | ||||||
June 30, 2019 | June 30, 2020 | ||||||
Profit | 1,883 | 1,649 | |||||
Other comprehensive income | |||||||
Valuation difference on available-for-sale securities | (12) | 1,707 | |||||
Foreign currency translation adjustments | (153) | (11) | |||||
Remeasurements of defined benefit plans | 2 | (1) | |||||
Total other comprehensive income | (163) | 1,694 | |||||
Comprehensive income | 1,719 | 3,343 | |||||
(Breakdown) | |||||||
Comprehensive income attributable to owners of parent | 1,742 | 3,346 | |||||
Comprehensive income attributable to non-controlling interests | (22) | (3) |
7
SHIP HEALTHCARE HOLDINGS, INC. (3360): Summary of Financial Statements for First Quarter of Fiscal Year Ending March 31, 2021
(3) Notes on quarterly consolidated financial statements
(Notes on the going concern assumption) Not applicable
(Notes on marked changes to shareholders' equity) Not applicable
(Segment information, etc.) [Segment information]
- Previous consolidated cumulative first quarter (April 1 - June 30, 2019) 1 Net sales and profit (loss) by reportable segment
(Unit: Millions yen) | |||||||||
Reportable segment | Amount | ||||||||
recorded on | |||||||||
Total Pack | Medical | Life Care | Dispensing | Other*1 | Total | Adjustments | quarterly | ||
*2 | consolidated | ||||||||
Produce | Supply | Pharmacy | Subtotal | ||||||
business | income | ||||||||
business | business | business | |||||||
statement*3 | |||||||||
Net sales | |||||||||
(1) Sales to outside | 19,332 | 75,882 | 5,976 | 6,621 | 107,812 | 1,192 | 109,005 | - | 109,005 |
customers | |||||||||
(2) Intersegment | 474 | 239 | 45 | 451 | 1,210 | 76 | 1,286 | (1,286) | - |
sales or transfers | |||||||||
Subtotal | 19,807 | 76,121 | 6,021 | 7,072 | 109,022 | 1,268 | 110,291 | (1,286) | 109,005 |
Segment profit | 1,141 | 788 | 441 | 624 | 2,996 | 99 | 3,095 | (64) | 3,030 |
Notes: |
- The "Other" category includes businesses not included in reportable business segments, such as the veterinary hospital business, sales of physical and chemical apparatus, and the security business.
- The figure of (64) million yen in adjustments to segment profit includes (23) million yen in cancellation of intersegment transactions and (41) million yen in companywide costs not allocated among reportable segments. These companywide costs consist mainly of parent company operating expenses and sales, general, and administrative expenses not attributable to individual reportable segments.
- Segment profit is adjusted against the operating profit reported on the quarterly consolidated statement of income.
2 Information on impairment loss on fixed assets or goodwill, per reporting segment
During this consolidated cumulative first quarter, no significant impairment loss on fixed assets and no significant change in amounts of goodwill or significant gains on negative goodwill were identified.
8
SHIP HEALTHCARE HOLDINGS, INC. (3360): Summary of Financial Statements for First Quarter of Fiscal Year Ending March 31, 2021
- Consolidated cumulative first quarter under review (April 1 - June 30, 2020) 1 Net sales and profit (loss) by reportable segment
(Unit: Millions yen)
Reportable segment | Amount | ||||||||
recorded on | |||||||||
Total Pack | Medical | Life Care | Dispensing | Other*1 | Total | Adjustments | quarterly | ||
*2 | consolidated | ||||||||
Produce | Supply | Pharmacy | Subtotal | ||||||
business | income | ||||||||
business | business | business | |||||||
statement*3 | |||||||||
Net sales | |||||||||
(1) Sales to outside | 16,806 | 74,275 | 6,069 | 6,551 | 103,702 | 1,753 | 105,455 | - | 105,455 |
customers | |||||||||
(2) Intersegment | 467 | 336 | 45 | 6,400 | 7,249 | 100 | 7,349 | (7,349) | - |
sales or transfers | |||||||||
Subtotal | 17,273 | 74,611 | 6,114 | 12,952 | 110,952 | 1,853 | 112,805 | (7,349) | 105,455 |
Segment profit | 976 | 850 | 580 | 446 | 2,855 | 86 | 2,941 | (53) | 2,887 |
Notes: |
- The "Other" category includes businesses not included in reportable business segments, such as the veterinary hospital business, sales of physical and chemical apparatus, and the security business.
- The figure of (53) million yen in adjustments to segment profit includes (21) million yen in cancellation of intersegment transactions and (32) million yen in companywide costs not allocated among reportable segments. These companywide costs consist mainly of parent company operating expenses and sales, general, and administrative expenses not attributable to individual reportable segments.
- Segment profit is adjusted against the operating profit reported on the quarterly consolidated statement of income.
-
Information on assets of each reportable segments
During the first quarter of the current consolidated cumulative period, the Company acquired the shares of STK Co., Ltd. and it is included in the scope of consolidation. The Company also acquired equity interests of Charm Care Corporation., and it is included in the scope the equity-method applied.
Due to the above acquisition, assets in "Life Care business" segment increased by 9,859 million yen from the end of the previous consolidated fiscal year. - Information on impairment losses on non-current assets or goodwill of each reportable segments
(Significant impairment losses on non-current assets) Not applicable.
(Significant changes in the amount of goodwill)
During the first quarter of the current consolidated cumulative period, the Company acquired the shares of Okkar Thiri Co., Ltd. and Snow Everest Co., Ltd., and they are included in the scope of consolidation.
The increase in goodwill in "Total Pack Produce business" segment due to the above event is 3,013 million yen.
(Significant gain on negative goodwill) Not applicable.
9
Attachments
- Original document
- Permalink
Disclaimer
Ship Healthcare Holdings Inc. published this content on 07 August 2020 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 07 August 2020 06:33:19 UTC